Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Modern Pharma Requires A Central Nervous System For Assets
Ed Garibian, LLumin CEO and software entrepreneur, has 35 years of experience in machine maintenance, asset management & IoT technologies. Within manufacturing environments, equipment breakdown is an expensive inconvenience. In pharma, it is a…
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
Company announcement No. 28 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 26, 2026) Copenhagen, Denmark, June 29, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
One Nation's new MP owns five properties, pharma stocks
One Nation's newly elected federal MP David Farley has disclosed a raft of financial interests, including stakes in obscure ASX-listed stocks, trading accounts and an expansive property portfolio. Under current lower house guidelines, all MPs must…
Zydus, Sunshine launch US$20 million pharma plant in Horana to boost local drug manufacturing
Sri Lanka's drive to strengthen domestic pharmaceutical manufacturing received a major boost last week with the launch of a US$20 million joint venture between India's Zydus Lifesciences and Sri Lanka's Sunshine Healthcare to establish a modern…
Rockefeller Capital Management L.P. Purchases 81,747 Shares of Royalty Pharma PLC $RPRX
Rockefeller Capital Management L.P. increased its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1,347.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
Pictet Asset Management Holding SA Raises Stake in BridgeBio Pharma, Inc. $BBIO
Pictet Asset Management Holding SA increased its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 8.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor…
Stock Market Opening Bell: Sensex Falls 0.06%, Nifty 50 Surges 0.02% - Here's Why
Stock Market Opening Bell: The Indian benchmark stock market indices opened, following a mixed trend in global markets post fresh escalations in US-Iran war over the weekend. While Nifty 50 opened 0.02% higher at 77055.21 level, Sensex fell as much…
Israeli health-tech conference opens in Jerusalem with 1,800 participants
The Israel Advanced Technology Industries (IATI) opened MIXiii Health-Tech.IL 2026 in Jerusalem on Monday, bringing roughly 1,800 participants and representatives from more than 40 countries to the International Convention Center, organizers said.
BridgeBio: 3 New Drug Approvals In Sight Outweigh Attruby Issues, Still Bullish (BBIO)
BridgeBio Pharma, Inc. remains a Buy, driven by Attruby's commercial launch and a robust late-stage pipeline targeting rare genetic diseases. BBIO's $14bn+ valuation is underpinned by four potential blockbuster drugs by 2030, with key NDA catalysts…
Dachser Korea director named new head of German Chamber of Commerce
The managing director of logistics firm Dachser's Korean office has been named as the new head of the Korean-German Chamber of Commerce and Industry (KGCCI). KGCCI said Monday it appointed Dachser Korea's Christoph Nowak as its new German chairman.
Nifty prediction today - June 29, 2026: Nifty futures may witness a brief blip before rally
Nifty 50 began today's session flat at 24,062 versus last week's close of 24,056. It is now trading at 24,060. The advance/decline ratio of Nifty 50 currently stands at 29/21, showing a bullish bias. Dr Reddy's Laboratories, up nearly 4 per cent…
Danaher: Why I'm Not Paying 24x P/E For 8% EPS Growth (NYSE:DHR)
Danaher (DHR) is a high-quality life sciences holding company, but current valuation does not justify a buy. DHR's reliance on M&A and exposure to pharma spending cycles pose risks, with organic growth slowing to just above 4% AEPS in 2025. Despite…
Jahangir Aziz: 'Investment is casualty when industry concentration rises'
The problem comes when you look at where the money went into the stock market. Most of it has gone into AI-related stocks, which have been broadening. It hasn't gone into the mainstream economy. Apart from people moving to US equity markets, they…
Sensex drops over 300 points, Nifty slips as geopolitical tensions weigh on markets
Equity benchmarks traded lower in Monday's mid-session after a flat opening following a long weekend, as renewed geopolitical tensions weighed on investor sentiment. Domestic markets remained cautious after fresh military exchanges between the US…
George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations
Brendan Walsh brings more than 20 years of operational leadership to support George Medicines' global commercial expansion of GMRx2 London, UK, Boston, MA, 29 June 2026 – George Medicines, a late-stage biopharmaceutical company focused on…
Receive a Daily briefing on Pharma Industry News
Get Started